New Antibody for
COVID-19
Check characteristics of Covid-19, an antiviral treatment mechanism of action, current status of the treatment development and the latest news.
Biologics
that are more approachable
Celltrion's antibody biosimilars provide patients
with high-quality yet affordable
Pharmaceuticalsreinnovated
By venturing into the $833 billion global pharmaceutical market,
we are excited to provide affordable healthcare for more patients around the world
Pioneering into the
future
Celltrion has shifted the pharmaceutical paradigm
with outstanding biopharmaceutical products,
Research and Development capabilities, and expertise
